95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.83%
Revenue growth under 50% of NEM's 18.66%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
12.55%
Gross profit growth under 50% of NEM's 40.74%. Michael Burry would be concerned about a severe competitive disadvantage.
-10.38%
Negative EBIT growth while NEM is at 46.69%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-10.38%
Negative operating income growth while NEM is at 46.69%. Joel Greenblatt would press for urgent turnaround measures.
-79.93%
Negative net income growth while NEM stands at 101.38%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-81.25%
Negative EPS growth while NEM is at 101.41%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-81.25%
Negative diluted EPS growth while NEM is at 101.37%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.17%
Share change of 0.17% while NEM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.23%
Diluted share change of 0.23% while NEM is zero. Bruce Berkowitz might see a minor difference that could widen over time.
1.54%
Maintaining or increasing dividends while NEM cut them. John Neff might see a strong edge in shareholder returns.
0.04%
OCF growth under 50% of NEM's 74.12%. Michael Burry might suspect questionable revenue recognition or rising costs.
126.84%
FCF growth 50-75% of NEM's 211.92%. Martin Whitman would see if structural disadvantages exist in generating free cash.
222.40%
10Y revenue/share CAGR above 1.5x NEM's 29.99%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-5.56%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-11.09%
Negative 3Y CAGR while NEM stands at 7.49%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
210.51%
10Y OCF/share CAGR 1.25-1.5x NEM's 175.25%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
-29.99%
Negative 5Y OCF/share CAGR while NEM is at 81.88%. Joel Greenblatt would question the firm’s operational model or cost structure.
-26.27%
Negative 3Y OCF/share CAGR while NEM stands at 159.30%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
108.33%
Positive 10Y CAGR while NEM is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-94.15%
Negative 5Y net income/share CAGR while NEM is 100.16%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
103.66%
3Y net income/share CAGR similar to NEM's 100.75%. Walter Schloss would attribute it to shared growth factors or demand patterns.
254.23%
10Y equity/share CAGR above 1.5x NEM's 25.96%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
23.55%
Positive 5Y equity/share CAGR while NEM is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
12.98%
Positive short-term equity growth while NEM is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
-13.85%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
77.66%
Below 50% of NEM's 410.59%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
118.02%
AR growth well above NEM's 27.21%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
-1.76%
Negative asset growth while NEM invests at 0.76%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.46%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-8.44%
We’re deleveraging while NEM stands at 1.69%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
156.46%
SG&A growth well above NEM's 6.78%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.